Gambro acquires clinics in the US

Gambro acquires clinics in the US Stockholm, Sweden - Gambro AB (Stockholm Stock Exchange: GAMBaST, GAMBbST), a leading international healthcare company, has acquired three dialysis clinics and an acute dialysis program in the state of California. The acquisition, which is made through the subsidiary Gambro Healthcare, Inc., is effective January 1, 1999. The clinics serve a total of 170 patients in the California communities of Roseville, Auburn, Sacramento and Grass Valley. Gambro Healthcare is the second largest provider of kidney dialysis services in the US. The company now owns, operates, manages or provides consulting services to 448 dialysis centers in the US that serve about 33,500 patients. There are patients under treatment in centers across 33 states and the District of Columbia. Gambro provides dialysis services to approximately 40,000 patients worldwide. For further information please contact: Bengt Modéer, Senior Vice President, Corporate Communications, tel. +46-8-613 65 00, +46-70-513 65 33 Anna Augustson, European Investor Relations Manager, tel. +46-8-613 65 35, +46-70-513 65 34 Gambro is a global healthcare company with leading positions in renal care - services and products - and blood component technology (BCT). Gambro is the second largest provider of kidney dialysis services in the world. Gambro treats about 40,000 patients in 460 clinics worldwide. Renal care products comprise dialyzers, dialysis machines, blood lines and dialysis fluid. BCT includes products for the separation and handling of blood components. The Group, with revenue of approximately SEK 18 billion (USD 2.3 billion) has 17,000 employees in some 40 countries. ------------------------------------------------------------ Please visit http://www.bit.se for further information The following files are available for download: http://www.bit.se/bitonline/1999/01/26/19990126BIT00310/bit0001.doc http://www.bit.se/bitonline/1999/01/26/19990126BIT00310/bit0002.pdf

About Us

Gambro is a global medical technology and healthcare company with leading positions in renal care - services and products - and blood component technology. The group, with revenue of approximately SEK 18 billion (USD 2.2 billion), has approximately 17,000 employees in some 40 countries.

Subscribe